Literature DB >> 28130086

The opioid antagonist, β-funaltrexamine, inhibits lipopolysaccharide-induced neuroinflammation and reduces sickness behavior in mice.

Randall L Davis1, Craig W Stevens2, J Thomas Curtis3.   

Abstract

Brain pathologies such as neurodegenerative diseases, infection, traumatic brain injury, and mood disorders produce enormous personal and economic burdens. It is well established that neuroinflammation plays an important role in the etiology and/or manifestation of such disorders. Previously, we discovered that beta-funaltrexamine (β-FNA) inhibits inflammatory signaling in human astrocytes in vitro, resulting in reduced expression of proinflammatory cytokines/chemokines. The present study examines the effects of peripherally administered β-FNA on lipopolysaccharide (LPS)-induced neuroinflammation and sickness behavior in vivo. Adult male C57BL/6J mice were administered β-FNA and were then immediately administered bacterial lipopolysaccharide (LPS). At 24h post-injections, sickness behavior was assessed in an open-field test. Following behavioral analysis plasma and brains were collected. Levels of interleukin-6 (IL-6), interferon-γ inducible protein-10 (CXCL10), and monocyte chemoattractant protein-1 (CCL2) were determined by enzyme-linked immunosorbant assay (ELISA). At 24h post-LPS injection, IL-6, CCL2 and CXCL10 were increased in the plasma, whereas, only CCL2 and CXCL10 were elevated in the brain. β-FNA significantly inhibited LPS-induced CXCL10 and CCL2 expression in brain, but minimally or not at all in the plasma. LPS-induced sickness behavior, as indicated by a reduction in distance moved, was prevented by β-FNA. Overall, CXCL10 expression in the brain was most positively and significantly correlated with sickness behavior; whereas, anxiety-like behavior was most positively and significantly correlated with IL-6 and CCL2 levels in the plasma and levels of CXCL10 and CCL2 in the brain. The reduction in sickness behavior may be in part due to decreased chemokine expression in the brain; further examination of the anti-inflammatory and neuroprotective effects of β-FNA is warranted.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Chemokine; Cytokine; LPS; Opioid; β-FNA

Mesh:

Substances:

Year:  2017        PMID: 28130086     DOI: 10.1016/j.physbeh.2017.01.037

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  7 in total

1.  Critical Role of Monocyte Recruitment in Optic Nerve Damage Induced by Experimental Optic Neuritis.

Authors:  Marcos L Aranda; Diego Guerrieri; Gonzalo Piñero; María F González Fleitas; Florencia Altschuler; Hernán H Dieguez; María I Keller Sarmiento; Mónica S Chianelli; Pablo H Sande; Damián Dorfman; Ruth E Rosenstein
Journal:  Mol Neurobiol       Date:  2019-05-01       Impact factor: 5.590

2.  Lentivirus-mediated interleukin-1β (IL-1β) knock-down in the hippocampus alleviates lipopolysaccharide (LPS)-induced memory deficits and anxiety- and depression-like behaviors in mice.

Authors:  Mengmeng Li; Chenli Li; Hanjie Yu; Xiongxiong Cai; Xinbei Shen; Xin Sun; Jinting Wang; Yanhua Zhang; Chuang Wang
Journal:  J Neuroinflammation       Date:  2017-09-20       Impact factor: 8.322

3.  "Females Are Not Just 'Protected' Males": Sex-Specific Vulnerabilities in Placenta and Brain after Prenatal Immune Disruption.

Authors:  Amy E Braun; Pamela A Carpentier; Brooke A Babineau; Aditi R Narayan; Michelle L Kielhold; Hyang Mi Moon; Archana Shankar; Jennifer Su; Vidya Saravanapandian; Ursula Haditsch; Theo D Palmer
Journal:  eNeuro       Date:  2019-11-07

4.  Loss of APP in mice increases thigmotaxis and is associated with elevated brain expression of IL-13 and IP-10/CXCL10.

Authors:  Karina Mayagoitia; Andrew J Tolan; Shohali Shammi; Samuel D Shin; Jesus A Menchaca; Johnny D Figueroa; Christopher G Wilson; Denise L Bellinger; Abu Shufian Ishtiaq Ahmed; Salvador Soriano
Journal:  Physiol Behav       Date:  2021-07-19

5.  Curcumin Prevents Acute Neuroinflammation and Long-Term Memory Impairment Induced by Systemic Lipopolysaccharide in Mice.

Authors:  Vincenzo Sorrenti; Gabriella Contarini; Stefania Sut; Stefano Dall'Acqua; Francesca Confortin; Andrea Pagetta; Pietro Giusti; Morena Zusso
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810

6.  β-Funaltrexamine Displayed Anti-inflammatory and Neuroprotective Effects in Cells and Rat Model of Stroke.

Authors:  Chih-Cheng Wu; Cheng-Yi Chang; Kuei-Chung Shih; Chih-Jen Hung; Ya-Yu Wang; Shih-Yi Lin; Wen-Ying Chen; Yu-Hsiang Kuan; Su-Lan Liao; Wen-Yi Wang; Chun-Jung Chen
Journal:  Int J Mol Sci       Date:  2020-05-29       Impact factor: 5.923

7.  Single cell transcriptomics reveals opioid usage evokes widespread suppression of antiviral gene program.

Authors:  Tanya T Karagiannis; John P Cleary; Busra Gok; Andrew J Henderson; Nicholas G Martin; Masanao Yajima; Elliot C Nelson; Christine S Cheng
Journal:  Nat Commun       Date:  2020-05-26       Impact factor: 17.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.